BCL2 and lymphoma: In lymphoma diagnostics, particularly for DLBCL and HGBCL, a Hi-C-based lymphoma assay enables diagnosis-agnostic detection of gene fusions of IGH::MYC and IGH::BCL2, and rearrangements of MYC, BCL2, and BCL6, in a single assay [27].